Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
117.50    2.00 (1.73%)
Bid:
116.50
Ask:
117.50
Spread: 1.00 (0.858%)
Market Cap: £259.73m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Interim Management Statement

12 Feb 2009 10:32

RNS Number : 2127N
Queen's Walk Investment Limited
12 February 2009
Β 

ο»Ώ

Queen's Walk Investment Limited (the "Company")

12 February 2009

This interim management statement relates to the period fromΒ 30 SeptemberΒ 2008 toΒ 12 February 2009Β and has been prepared solely in order to comply with the requirement (pursuant to the EU Transparency Directive as implemented by the Disclosure and TransparencyΒ Rules) for an interim management statement to be made by the Company no earlier thanΒ 10Β DecemberΒ 2008 and no later thanΒ 17 February 2009. The Company is currently in the process of preparing its quarterly report for the period endedΒ 31 DecemberΒ 2008Β whichΒ is expected to be released inΒ March 2009.Β Β Unless otherwise notedΒ herein, the financial information provided in this interim management statement (and the asset valuations underlying that financial information) are as atΒ 30 SeptemberΒ 2008 and such financial information (and underlying valuations) will be stated as at a more recent date in the Company's forthcoming quarterly report.Β 

Performance Summary

As atΒ 30 SeptemberΒ 2008, theΒ Company's NAV was €4.95Β per share down from a NAV of €6.32Β per share as atΒ 30 June 2008. TheΒ decrease in NAVΒ reflected the expected deterioration in theΒ UKΒ and continental European mortgage markets inΒ the Company'sΒ cash flow forecasts as atΒ 30 SeptemberΒ 2008.Β 

In the quarter ended 30 September 2008, the Company estimated cash flows for the December quarter of €7.0Β millionΒ (using 31 December 2008 FX rates). Actual cash flows recorded in the quarter ended 31 December 2008Β were €7.8 million.Β The Company hadΒ a net cash balance of €9.3mΒ asΒ atΒ 12Β FebruaryΒ 2009Β (followingΒ payment in January 2009 of €2.1 million forΒ the September 2008 dividend, €1 million for the purchase of aΒ partialΒ option hedge against the MDAX indexΒ andΒ paymentΒ of €5.5 millionΒ to reduce the principalΒ ofΒ its financingΒ facility).

In November 2008 the Company renegotiated its financingΒ facility,Β therebyΒ reducing itsΒ debtΒ and agreeing to a flexible two year repayment schedule of the outstanding debt. The revised agreement reduced the risk associated with material change clauses that could have forced a repayment of the debt on unfavourable terms. Following the repayment of €5.5 million of the facility in January 2009, theΒ current outstanding amount of €29.5 millionΒ is already significantlyΒ lower thanΒ the agreedΒ target loan amountΒ atΒ 31Β MarchΒ 2009 of €33Β million.

Investment Portfolio

The tables below summarise the Company's investment portfolio as atΒ 30 SeptemberΒ 2008.

Portfolio Composition by Jurisdiction as atΒ 30 SeptemberΒ 2008*

*By reference to underlying asset jurisdiction. Figures stated as a percentage of the fair value of the Company's residual investments including accrued interest.

Jurisdiction

%

PortugalΒ 

35.1%

UK

13.9%

Germany

24.9%

Italy

15.0%

Holland

8.6%

CDO

2.0%

France

0.5%

US

0.0%

Portfolio Composition by Asset Type as atΒ 30 SeptemberΒ 2008*

*By reference to underlying asset collateral. Figures stated as a percentage of the fair value of the Company's residual investments including accrued interest.Β 

Portfolio CompositionΒ 

%

Prime

51.0%

SME

31.8%

Investment Grade Bonds

6.1%

SubPrime

5.7%

NearPrime

3.4%

Β CDO

2.0%

As atΒ 12 February 2009, the securitisations to which the Company had exposure through itsΒ residualΒ investment portfolio were:

Issuer

Description of Underlying Assets

Alba 2005-1 plc

UKΒ non-conforming*Β and buy-to-let residential mortgages

Β 

Alba 2006-1 plc

UKΒ non-conforming residential mortgages, primarily first-ranking

Β 

Amstel Corporate Loan Offering BV 2006-1

Middle market corporate loans

Cheyne CLO Investments I Limited

Investment grade CLOs

Cheyne High Grade ABS CDO, Ltd

Investment grade ABS CDOs with exposure to theΒ USΒ sub-prime mortgage market

Earls Eight Limited (Tranche 312B)

SME loans

Eirles Three Limited (Tranche 227B)

SME loans

Eirles Three Limited (Tranche 236B)Β 

SME loans

Eurosail 2006-1 plc

UKΒ non-conforming and buy-to-let residential mortgages

Lusitano Mortgages No. 1 plc

First-ranking, fully amortising Portuguese residential mortgages

Β 

Lusitano Mortgages No. 2 plc

First-ranking, fully amortising Portuguese residential mortgages

Β 

Lusitano Mortgages No. 3 plc

First-ranking, fully amortising Portuguese residential mortgages

Β 

Magellan Mortgages No. 1 plc

First ranking, fully amortising Portuguese residential mortgages

Β 

Magellan Mortgages No. 2 plc

First ranking mortgage rights (or second-ranking where first-ranking is also transferred) Portuguese residential mortgages

Β 

Newgate Funding plc

UKΒ non-conforming residential mortgages, primarily first-ranking

Β 

RASC Series 2006-KS2 Trust

US Sub-prime residential mortgages, primarily first-ranking

RMAC 2004-NSP4 plc

UKΒ non-conforming residential mortgages, primarily first-ranking

Β 

RMAC 2005 NS3 plcΒ 

UKΒ non-conforming residential mortgages, primarily first-ranking

Β 

RMAC 2005 NS4 plc

UKΒ non-conforming residential mortgages, primarily first-ranking

Β 

Sestante Finance S.R.L.

First-ranking prime Italian residential mortgages

Β 

*Non-conforming relates to subprime and near prime residential mortgages.

Since JulyΒ 2008, the Company hasΒ spent €6.5Β millionΒ (using FX rates at dates of purchase) purchasingΒ tenΒ investment grade asset backed securities (ABS).Β These securities have exposure to residential andΒ commercial mortgage portfolios. The table below summarises the Company's ABS exposure by sector and rating at the time of purchase.

Percentage of Portfolio by Value

Rating by Type

UKΒ RMBS

UKΒ Buy to Let

UKΒ Non-Conforming RMBS

EUR CMBS

Total

AAA

16.86%

1.98%

18.84%

AA

31.83%

31.83%

A

15.50%

4.52%

20.02%

BBB

12.33%

16.99%

29.31%

Total

12.33%

48.69%

15.50%

23.48%

100.00%

Outlook

TheΒ global economy has experienced a significant slowdown as the effects of the credit crisis are no longer confined to the financial sector. The housing market in countries such as theΒ US,Β UK,Β SpainΒ andΒ IrelandΒ has deteriorated considerably and house prices in these regions are expected to continueΒ declining. Banks haveΒ continued toΒ reduce the availability of credit and tightened lending standards in response to weaker fundamentals and deteriorating capital bases.

InΒ 2008,Β the European securitisation marketsΒ for theΒ issuance of transactions to third party investors came to a near standstill. Securitisations thatΒ have beenΒ completed are often retained and used for collateral with either the Bank of England or the European Central Bank. Given continuedΒ market conditions, the securitisation marketsΒ remainΒ unlikely to provide financial institutions with an attractive source of funding in 2009.

In the quarter endedΒ 30 SeptemberΒ 2008,Β theΒ Company'sΒ write-downsΒ to theΒ UKΒ mortgage portfolio reflectedΒ an expectation of substantial deterioration in theΒ UKΒ economy. With respect to theΒ EuropeanΒ mortgage portfolio, the expected default rateΒ wasΒ increasedΒ in the September quarterΒ and the cash flow forecasts do not assume that credit quality will improve with falling Euribor rates.

The default ratesΒ of the SME portfolioΒ remain belowΒ or in line withΒ the forecastedΒ default rates. As such, the SME portfolio should be able to withstand a moderate increase in default rates in the coming quarters.Β However,Β to partiallyΒ hedge against any potential credit impact on the SME enterprises from the underlying pool of loans, the Company has purchasedΒ 3,385Β put options on the German Mid Cap Index (MDAX)Β at a strike price of 4,750Β points, for an aggregate purchase price of €1 million.

The CompanyΒ remainsΒ focusedΒ on reducing debt and continuing to selectively acquire assets undervalued by dislocated markets. In NovemberΒ 2008,Β the Company renegotiated its financing facility and agreed to a two year repayment schedule,Β which reducedΒ the risk of a material change forcing a repayment on unfavourable terms.Β As atΒ 12Β FebruaryΒ 2009Β the Company had made further repayments and the outstandingΒ debtΒ amount hadΒ been reduced to €29.5 million.

Since commencing its new investment programme inΒ July 2008, Queen's Walk has invested €6.5Β million inΒ tenΒ investment grade bonds.Β In conjunction with prudent management of the Company's financing facility, the Investment Manager will continue to use available cash proceeds to take advantage of investment opportunities in investment grade ABS. Current European ABS bond prices reflect credit scenarios that we believe are more pessimistic than economic forecasts suggest and also substantially worse than previous recessions.

Overall, Queen's WalkΒ continues to beΒ well positioned to take advantage of the current dislocation in the European ABS markets. The Company has taken pro-active steps to minimise its financing risk and willΒ continue toΒ take a prudent approach in managing its cash balances.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSDGGMZLZVGLZG
Date   Source Headline
29th Aug 20177:00 amRNSNotice of Suspension of Preference Shares
16th Aug 20177:00 amRNSNotice of Redemption of Preference Shares
10th Aug 20177:00 amRNSDividend Declaration
4th Aug 20177:00 amRNSFact Sheet Announcement
31st Jul 20177:00 amRNSNotice of AGM
11th Jul 201711:21 amRNSNotification of Major Interest in Shares
11th Jul 20177:00 amRNSFact Sheet Announcement
10th Jul 20173:52 pmRNSNotification of Major Interest in Shares
5th Jul 20174:10 pmRNSNotification of Major Interest in Shares
5th Jul 20173:06 pmRNSNotification of Major Interest in Shares
4th Jul 20178:45 amRNSClose of Second Placing
28th Jun 20177:00 amRNSProposed Placing of New Ordinary Shares
16th Jun 20171:00 pmRNSPublication of Supplementary Prospectus
16th Jun 20177:00 amRNSDividend Declaration - Ordinary Dividend
16th Jun 20177:00 amRNSAnnual Financial Report
6th Jun 20177:00 amRNSFact Sheet Announcement
23rd May 20177:00 amRNSDividend Declaration - Preference Dividend
19th May 201711:33 amRNSNotification of Major Interest in Shares
18th May 20171:41 pmRNSNotification of Major Interest in Shares
12th May 20177:00 amRNSNotice of Results
5th May 20177:00 amRNSFact Sheet Announcement
4th May 20177:00 amRNSPortfolio Investment Announcement
13th Apr 20177:00 amRNSFact Sheet Announcement
29th Mar 20174:08 pmRNSDirector/PDMR Shareholding
28th Mar 20179:10 amRNSNotification of Major Interest in Shares
24th Mar 20174:34 pmRNSNotification of Major Interest in Shares
24th Mar 201710:00 amRNSDirector/PDMR Shareholding
24th Mar 201710:00 amRNSDirector/PDMR Shareholding
24th Mar 201710:00 amRNSDirector/PDMR Shareholding
22nd Mar 20171:11 pmRNSResult of EGM
8th Mar 20177:00 amRNSFact Sheet Announcement
2nd Mar 20171:13 pmRNSNotification of Major Interest in Shares
23rd Feb 20173:00 pmRNSClose of Initial Placing
23rd Feb 20171:00 pmRNSPublication of Prospectus and Initial Placing
9th Feb 201712:10 pmRNSProposed Placing Programme and Initial Placing
8th Feb 20173:00 pmRNSDividend Declaration - Preference Dividend
8th Feb 20173:00 pmRNSDividend Declaration - Ordinary Dividend
7th Feb 20177:00 amRNSFact Sheet Announcement
6th Feb 201711:36 amRNSNotification of Major Interest in Shares
6th Jan 20177:00 amRNSFact Sheet Announcement
7th Dec 20167:00 amRNSFact Sheet Announcement
30th Nov 20167:00 amRNSDividend Declaration - Preference Dividend
30th Nov 20167:00 amRNSDividend Declaration - Ordinary Dividend
30th Nov 20167:00 amRNSCondensed Interim Financial Report
30th Nov 20167:00 amRNSHalf-year Report
3rd Nov 20167:00 amRNSFact Sheet Announcement
25th Oct 201611:30 amRNSChange of Name
5th Oct 20167:00 amRNSFact Sheet Announcement
16th Sep 20162:00 pmRNSResult of AGM
7th Sep 20167:00 amRNSFact Sheet Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.